脑部放疗,上午比下午敏感许多!
6 ~& J; u4 L6 |; z4 B6 g- _6 [8 K9 W9 l4 o( O4 s
( J; ?0 I4 {0 a8 `) hCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
/ I L! }5 f l9 g3 \Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
' Q/ S" o# o3 N0 K- a; l3 fRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.3 [2 D6 x# N; B6 K
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
& I) s& {4 d1 T5 r9 P* p" _
) q7 J4 O/ a! B2 C5 L* ~ `Abstract
! O4 c9 K& Y5 n' y6 t7 C( \BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
+ x) v( ]6 j: J, S' o0 K: M* w7 h, c0 F" V8 V7 ]' a5 J4 b
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
" j2 k; w* I$ z. V% l4 ~5 L3 T9 c* ?! @7 E- p/ I; Y9 P
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
8 o% A- }! s' Y0 e$ ~. j4 l5 E. S
+ F. h5 i7 G# Z% I. b3 c. L$ J$ l' O& XCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
8 ?, x1 V: T2 h8 |- H$ e! P7 H( D5 m
|